Speakers
Interactive workshop
Establishing the right IP strategy is essential in creating market exclusivity and attracting investment. In this session, Edward will discuss how to recognise and capture IP assets, prevent value leakage, and explain how to approach dealing with your competitors’ IP rights. Practical examples of successes and failures in IP strategy will be discussed.
Edward advises both UK and US biotechnology and medical device companies on protecting valuable inventions.
His sector expertise spans antibodies, cell and gene therapy, gene editing, stem cells, therapeutics, diagnostics, molecular biology and medical devices.
For these technologies, Edward’s work includes patent drafting, patent prosecution, European Patent Office (EPO) opposition and appeals, proceedings at the Intellectual Property Enterprise Court (IPEC), freedom to operate reports, and registered designs.
Edward completed his PhD in virology from Warwick University in 2006 studying rotavirus replication. After leaving Warwick University, he worked as a postdoctoral research associate at the University of Virginia researching the rhabdovirus nucleocapsid protein. Edward returned to the UK in 2009 to study for his master’s in intellectual property law at Queen Mary University of London. Edward entered the patent profession in private practice in 2010.